Keywords: Tumors (Post-Treatment), DSC & DCE Perfusion
Motivation: The differential diagnosis of true tumor progression and treatment-related effects using conventional MRI remains challenging in primary or secondary brain tumors after treatment.
Goal(s): To investigate whether combined DCE and DSC MRI can improve diagnostic accuracy.
Approach: We enrolled patients with treated glioblastoma or brain metastases who showed enlarged enhancing lesion in the treated bed. DCE and DSC sequences were included in their standard brain MRI scans. We calculated key parameters from DCE and DSC images and analyzed the diagnostic accuracy individually and in combination.
Results: Ktrans_mean outperformed other imaging biomarkers. A combined Ktrans_mean and rCBV_mean achieved excellent diagnostic accuracy.
Impact: Combined DCE and DSC demonstrated excellent diagnostic accuracy in differentiating treatment-related effects and brain tumor progression when an enlarged enhancing lesion was first spotted on MRI. It could allow physicians to early evaluate treatment response and make decisions accordingly.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords